Abstract
How do we forecast an emerging pandemic in real time in a purely data-driven manner? How to leverage rich heterogeneous data based on various signals such as mobility, testing, and/or disease exposure for forecasting? How to handle noisy data and generate uncertainties in the forecast? In this paper, we present DeepCovid, an operational deep learning framework designed for real-time COVID-19 forecasting. Deep-Covid works well with sparse data and can handle noisy heterogeneous data signals by propagating the uncertainty from the data in a principled manner resulting in meaningful uncertainties in the forecast. The framework also consists of modules for both real-time and retrospective exploratory analysis to enable interpretation of the forecasts. Results from real-time predictions (featured on the CDC website and FiveThirtyEight.com) since April 2020 indicates that our approach is competitive among the methods in the COVID-19 Forecast Hub, especially for short-term predictions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This paper is based on work supported by the NSF (Expeditions CCF-1918770, CAREER IIS-1750407, RAPID IIS-2027862, Medium IIS-1955883, NRT DGE-1545362), CDC MInD-Healthcare U01CK000531-Supplement, funds from Georgia Tech Research Institute (GTRI) and funds/computing resources from Georgia Tech.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
arodriguezc{at}gatech.edu, jiamingcui1997{at}gatech.edu, jxie{at}gatech.edu, jho67{at}gatech.edu, pulak.agarwal{at}gatech.edu, badityap{at}gatech.edu, anikat1{at}vt.edu, bijaya-adhikari{at}uiowa.edu
Data Availability
All data are publicly available. https://github.com/CSSEGISandData/COVID-19 https://covidtracking.com/ https://cmu-delphi.github.io/delphi-epidata/ https://www.google.com/covid19/mobility https://www.apple.com/covid19/mobility
